TR201902542T4 - Glokom i̇çi̇n tani yöntemleri̇ - Google Patents

Glokom i̇çi̇n tani yöntemleri̇ Download PDF

Info

Publication number
TR201902542T4
TR201902542T4 TR2019/02542T TR201902542T TR201902542T4 TR 201902542 T4 TR201902542 T4 TR 201902542T4 TR 2019/02542 T TR2019/02542 T TR 2019/02542T TR 201902542 T TR201902542 T TR 201902542T TR 201902542 T4 TR201902542 T4 TR 201902542T4
Authority
TR
Turkey
Prior art keywords
glocom
glaucoma
diagnosis methods
autoimmune reactivity
analysis
Prior art date
Application number
TR2019/02542T
Other languages
English (en)
Turkish (tr)
Inventor
Grus Franz
Boehm Nils
Pfeiffer Norbert
Bell Katharina
Original Assignee
M Lab Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by M Lab Gmbh filed Critical M Lab Gmbh
Publication of TR201902542T4 publication Critical patent/TR201902542T4/tr

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/16Ophthalmology
    • G01N2800/168Glaucoma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rehabilitation Therapy (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Rheumatology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TR2019/02542T 2010-04-13 2011-04-13 Glokom i̇çi̇n tani yöntemleri̇ TR201902542T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US34236310P 2010-04-13 2010-04-13

Publications (1)

Publication Number Publication Date
TR201902542T4 true TR201902542T4 (tr) 2019-03-21

Family

ID=43984128

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/02542T TR201902542T4 (tr) 2010-04-13 2011-04-13 Glokom i̇çi̇n tani yöntemleri̇

Country Status (17)

Country Link
US (1) US10175251B2 (https=)
EP (1) EP2558862B1 (https=)
JP (2) JP2013529292A (https=)
KR (1) KR101903193B1 (https=)
CN (1) CN103003693B (https=)
AU (1) AU2011241402B2 (https=)
BR (1) BR112012026219B1 (https=)
CA (1) CA2795270C (https=)
DK (1) DK2558862T3 (https=)
ES (1) ES2712060T3 (https=)
HR (1) HRP20190278T1 (https=)
HU (1) HUE042703T2 (https=)
PL (1) PL2558862T3 (https=)
RU (1) RU2657515C2 (https=)
TR (1) TR201902542T4 (https=)
WO (1) WO2011127616A1 (https=)
ZA (1) ZA201207935B (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140147413A1 (en) * 2011-02-28 2014-05-29 Dong Feng Chen Therapies That Target Autoimmunity For Treating Glaucoma And Optic Neuropathy
WO2012118796A1 (en) 2011-02-28 2012-09-07 The Schepens Eye Research Institute, Inc. Compositions for controlling neuronal outgrowth
WO2013126465A1 (en) * 2012-02-21 2013-08-29 MEDEIROS, Felipe, A. Systems and methods for determining retinal ganglion cell populations and associated treatments
ES2759026T3 (es) * 2013-02-26 2020-05-07 Inst Oftalmologico Fernandez Vega S L Método para el diagnóstico de glaucoma basándose en la determinación de niveles de proteínas séricas
US20170239331A1 (en) * 2014-10-15 2017-08-24 Rapid Pathogen Screening, Inc. Formulations for histatin protectives and therapeutics
JP6499918B2 (ja) 2015-05-20 2019-04-10 株式会社トプコン 眼科検査支援システム及び眼科検査支援サーバ
RU2617066C1 (ru) * 2016-04-01 2017-04-19 Федеральное государственное автономное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения Российской Федерации Способ определения показаний к интравитреальному введению цилиарного нейротрофического фактора при лечении заболеваний зрительно-нервного аппарата глаза
CN110213987A (zh) 2016-12-05 2019-09-06 杰克逊实验室 视网膜和视神经中的脂肪滴作为人类的神经变性和青光眼的诊断标志物
JP7202609B2 (ja) * 2017-12-13 2023-01-12 国立大学法人東北大学 視神経障害の診断用バイオマーカー
CN108229545B (zh) * 2017-12-22 2021-09-14 北京市商汤科技开发有限公司 青光眼诊断的方法、装置及电子设备
EP3934674A4 (en) * 2019-03-04 2022-11-16 The Schepens Eye Research Institute, Inc. MODULATION OF NERVOUS INFLAMMATION
CN111856037B (zh) * 2020-07-31 2021-06-22 四川大学华西第二医院 Unc45a与hsp10的比值在pop早期预警、诊断、预后评估中的应用和产品
KR102596340B1 (ko) 2020-08-25 2023-11-02 사회복지법인 삼성생명공익재단 안질환 시야 손상 예후 예측 시스템 및 방법과 이를 위한 컴퓨터 프로그램
CN113444789A (zh) * 2021-08-27 2021-09-28 中国医学科学院北京协和医院 青光眼相关生物标志物及其应用
CN114965664A (zh) * 2022-03-21 2022-08-30 上海交通大学 一种获取泪液代谢指纹谱图的方法及筛选方法
CN118425510B (zh) * 2024-05-17 2024-11-19 上海市第一人民医院 一种青光眼诊断的生物标志物及其应用

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9419267D0 (en) * 1994-09-23 1994-11-09 Unilever Plc Assay devices
RU2187983C2 (ru) * 1998-11-10 2002-08-27 Государственное учреждение Межотраслевой научно-технический комплекс "Микрохирургия глаза" Способ диагностики характера течения глаукомы
US20030149997A1 (en) 1999-02-19 2003-08-07 Hageman Gregory S. Diagnostics and therapeutics for arterial wall disruptive disorders
US20020102581A1 (en) * 1999-02-19 2002-08-01 Hageman Gregory S. Diagnostics and therapeutics for ocular disorders
US7011952B2 (en) * 2000-02-22 2006-03-14 University Of Iowa Research Foundation Diagnostics and therapeutics for macular degeneration-related disorders
JP4764590B2 (ja) * 2000-04-29 2011-09-07 ユニバーシティー オブ アイオワ リサーチ ファウンデーション 黄班変性関連疾患の診断および治療
CN1393470A (zh) * 2001-06-29 2003-01-29 上海博德基因开发有限公司 一种多肽——beta转导素-45.65和编码这种多肽的多核苷酸
ATE526041T1 (de) * 2001-12-11 2011-10-15 Fibrogen Inc Verfahren zur hemmung okularer vorgänge
AU2003249227A1 (en) * 2002-07-12 2004-02-02 University Of Washington Methods and systems for extended in vitro culture of neuronal cells
US20060166268A1 (en) * 2002-10-18 2006-07-27 Rescom Gmbh Diagnosis of glaucoma by complex autoantibody repertoires in body fluids
US7662389B2 (en) * 2003-12-17 2010-02-16 Alcon, Inc. Use of serum amyloid A gene in diagnosis and treatment of glaucoma and identification of anti-glaucoma agents
SG149814A1 (en) * 2003-12-19 2009-02-27 Omega Bio Pharma Ip3 Ltd Compositions and methods for treating diabetes
US20100004156A1 (en) * 2005-07-27 2010-01-07 Shalesh Kaushal Small Compounds That Correct Protein Misfolding and Uses Thereof
EP1832600A1 (en) * 2006-03-09 2007-09-12 Max-Delbrück-Centrum Für Molekulare Medizin Peptides against autoantibodies associated with glaucoma and use of these peptides
RU2314535C1 (ru) 2006-07-05 2008-01-10 Федеральное государственное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова Федерального агентства по здравоохранению и социальному развитию" Способ диагностики начальной стадии открытоугольной глаукомы
JP2010507069A (ja) * 2006-07-08 2010-03-04 ユニバーシティー オブ ケンタッキー リサーチ ファンデーション 肺癌診断アッセイ
EP1929937A1 (de) * 2006-12-07 2008-06-11 F. Hoffmann-Roche AG Vorrichtung und Verfahren zum Untersuchen von Körperflüssigkeiten
RU2371721C2 (ru) * 2007-06-25 2009-10-27 Закрытое акционерное общество "Молекулярно-медицинские технологии" Устройство для диагностики с использованием биочипов
GB0724412D0 (en) * 2007-12-14 2008-02-06 Ucl Business Plc Marker
KR101188439B1 (ko) * 2008-04-02 2012-10-08 (주)루미아이제네틱스 녹내장 진단용 키트
EP2354792A1 (en) 2010-02-08 2011-08-10 Biomonitor A/S Method for detecting anti-drug antibodies
KR20100087276A (ko) 2010-07-21 2010-08-04 (주)루미아이제네틱스 녹내장 진단용 키트
KR20100087275A (ko) 2010-07-21 2010-08-04 (주)루미아이제네틱스 녹내장 진단용 키트

Also Published As

Publication number Publication date
JP2016048265A (ja) 2016-04-07
CA2795270C (en) 2021-06-08
CA2795270A1 (en) 2011-10-20
RU2012147551A (ru) 2014-05-20
BR112012026219A2 (pt) 2016-07-12
AU2011241402B2 (en) 2016-09-15
EP2558862B1 (en) 2018-11-21
DK2558862T3 (en) 2019-03-18
KR20130122706A (ko) 2013-11-08
JP6225157B2 (ja) 2017-11-01
KR101903193B1 (ko) 2018-10-01
EP2558862A1 (en) 2013-02-20
WO2011127616A1 (en) 2011-10-20
JP2013529292A (ja) 2013-07-18
RU2657515C2 (ru) 2018-06-14
US10175251B2 (en) 2019-01-08
US20130172204A1 (en) 2013-07-04
ZA201207935B (en) 2019-07-31
AU2011241402A1 (en) 2012-11-15
PL2558862T3 (pl) 2019-07-31
BR112012026219B1 (pt) 2019-12-10
CN103003693A (zh) 2013-03-27
HUE042703T2 (hu) 2019-07-29
HRP20190278T1 (hr) 2019-04-19
CN103003693B (zh) 2016-07-06
ES2712060T3 (es) 2019-05-09

Similar Documents

Publication Publication Date Title
TR201902542T4 (tr) Glokom i̇çi̇n tani yöntemleri̇
WO2014189269A3 (ko) 복합 의료 장치
EA201390150A1 (ru) Способы выявления сигнатур заболевания или патологических состояний в текучих средах организма
EA201490883A1 (ru) ПРИМЕНЕНИЕ АНТИТЕЛА К α-СИНУКЛЕИНУ ДЛЯ ДИАГНОСТИКИ ПОВЫШЕННОГО УРОВНЯ α-СИНУКЛЕИНА В МОЗГЕ
EA201590220A1 (ru) Состояние туберкулезной инфекции у индивидуума
RU2011118035A (ru) Способ диагностики функционального состояния системы микроциркуляции крови при вибрационной болезни
WO2011156740A3 (en) Diagnosis of myocardial autoimmunity in heart disease
WO2014197460A8 (en) Methods for diagnosing and treating bicuspid aortic valve and/or aortopathies
EP4273552A4 (en) In-vitro medical diagnostic system
RU2011135101A (ru) Способ диагностики степени выраженности полиневропатии конечностей от комбинированного воздействия комплекса неблагоприятных факторов
RU2014118282A (ru) Способ неинвазивной диагностики портальной гипертензии при хронических диффузных заболеваниях печени
RU2014135019A (ru) Способ диагностики меланомы хориоидеи
RU2013146702A (ru) Способ диагностики туберкулеза женских гениталий у пациенток с бесплодием
UA66979U (ru) Способ ранней диагностики болезни легг-кальве-пертеса
UA79063U (ru) Способ интегрированной диагностики возможности рецидивов алкогольной зависимости
WO2020243159A3 (en) Targets and methods of diagnosing and monitoring lyme disease
Shekhar et al. Prospective survey of functional gastrointestinal disorders in UK gastroenterology clinics: workload and its management
Özbay et al. Working at night in hospital environment is a risk factor for arterial stiffness
RU2010126490A (ru) Способ диагностики глиобластомы головного мозга
UA62344U (ru) Способ диагностики возбудителей заболеваний желудочно-кишечного тракта
CN202376138U (zh) 一次性超声波诊断仪探头
De Pasquale Anaphylaxis: case report
Hanta et al. Tuberculin Skin Test Positivity Among Patients With Rheumatologic Diseases: Experienced With 609 Patients
WO2010086874A8 (en) An evolution for the diagnosis of duodenal diseases by transabdominal ultrasonography
UA83946U (ru) Способ диагностики реактивного артрита у детей в возрасте от 4- x до 7- ми лет